ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of ALXN1210 in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03131219
Recruitment Status : Recruiting
First Posted : April 27, 2017
Last Update Posted : December 14, 2018
Sponsor:
Information provided by (Responsible Party):
Alexion Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 2019
  Estimated Study Completion Date : September 2021